SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases
SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for…
News
Mitsubishi Heavy Industries Thermal Transport Europe GmbH (MTTE) Selects ORBCOMM as Telematics Provider for Standard-Fit Program Outfitting Refrigerated Trailers in Europe
Provides MTTE customers with immediate access to reefer data to improve efficiency, streamline maintenance processes…
Eros Investments, Xfinite and Calvin Cheng partner to launch XelebX, World’s First Metaverse Members-Only Influencer Fan Club
– Members will get access to the XelebX club through tradable NFTs– XelebX will launch…
MetricStream Awarded Bronze Stevie® Award for ESGRC SaaS by 2022 International Business Awards®
LONDON–(BUSINESS WIRE)–MetricStream, the global market leader in integrated risk management (IRM) and governance, risk management…
Schlumberger and Cognite to Deliver Data-Driven Solutions at Scale for the Global Energy Industry
Enterprise Data Solution with an open, industrial platform will unlock customers’ operational data and deliver…
POINT Biopharma Prices Public Offering of Common Stock
INDIANAPOLIS, Sept. 13, 2022 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company”…
AST SpaceMobile Confirms Successful Launch of BlueWalker 3 Into Orbit
Engineers Have Established Communication, Stabilized and Taken Control of the Test Satellite MIDLAND, Texas–(BUSINESS WIRE)–$ASTS…
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in Canada
LA JOLLA, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
Quanergy Partners with Fabrinet to Expand Global Manufacturing of LiDAR Sensors
Fabrinet Will Help Quanergy Scale to Meet Growing Demand SUNNYVALE, Calif.–(BUSINESS WIRE)–Quanergy Systems, Inc., (NYSE:QNGY)…
NGM Bio Presents Updated Preliminary Findings from the Ongoing Phase 1b Dose Escalation Trial of NGM120 in Combination with Gemcitabine and Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer at AACR Special Conference: Pancreatic Cancer
NGM120 is a novel antagonist antibody that binds GFRAL and inhibits GDF15 signaling for the…
InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
VANCOUVER, British Columbia, Sept. 13, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholangiocarcinoma
Lille (France), Cambridge (Massachusetts, United States), September 13, 2022 – GENFIT (Nasdaq and Euronext: GNFT),…
POINT Biopharma Announces Proposed Public Offering of Common Stock
INDIANAPOLIS, Sept. 13, 2022 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company”…
Zealand Pharma grants warrants to employees in Denmark
Company announcement – No. 40 / 2022 Zealand Pharma grants warrants to employees in Denmark…
Connect Biopharma Reports First Half 2022 Financial Results and Provides Business Update
– Company expects to report top-line data from China pivotal trial for lead drug candidate…
LAVA Therapeutics Provides Business Update and Reports Second Quarter Financial Results
Initial Phase 1/2a clinical findings for LAVA-051 in patients with chronic lymphocytic leukemia and multiple…
Akero Therapeutics Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO),…
Sanofi: Information concerning the total number of voting rights and shares – August 2022
Information concerning the total number of voting rights and shares, provided pursuant to article L….
Evertz Technologies Reports First Quarter Results for the Quarter Ended July 31, 2022
Burlington, Ontario–(Newsfile Corp. – September 13, 2022) – Evertz Technologies Limited (TSX: ET), the leader…
Starbucks Enters New Era of Growth Driven by an Unparalleled Reinvention Plan
Introduces Three-Year Financial Roadmap, Delivering Annual 7-9% Comparable Store Sales Growth, 10-12% Revenue Growth, and…